Jump to Navigation

Publicaties 2002

  • Publicaties 2002:
  • Davenport MP, Zaunders JJ, Hazenberg MD, Schuitemaker H, van Rij RP. Cell turnover and cell tropism in HIV-1 infection. TRENDS MICROBIOL 2002;10(6):275-278.     [ PubMed ]

 

  • de Boer F, Dräger AM, Pinedo HM, Kessler FL, van der Wall E, Jonkhoff AR, van der Lelie J, Huijgens PC, Ossenkoppele GJ, Schuurhuis GJ. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. BONE MARROW TRANSPL 2002;29(3):249-255.     [ PubMed ]

 

  • de Haas V , Breunis WB, dee R, Verhagen OJHM, Kroes W, van Wering ER, van Dongen JJM, van den Berg H, van der Schoot CE. The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia. BRIT J HAEMATOL 2002;116(1):87-93.     [ PubMed ]

 

  • de Haas V , Kaspers GJL, Oosten L, Bresters D, Pieters R, van der Velden VHJ, van Wering ER, van den Berg H, van der Schoot CE. Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?. BRIT J HAEMATOL 2002;118(4):1190-1191.     [ PubMed ]

 

  • de Haas V , Vet RJWM, Verhagen OJHM, Kroes W, van den Berg H, van der Schoot CE. Early detection of central nervous system relapse by polymerase chain reaction in children with B-precursor acute lymphoblastic leukemia. ANN HEMATOL 2002;81(1):59-61.     [ PubMed ]

 

  • Derksen PWB, Keehnen RMJ, Evers LM, van Oers MHJ, Spaargaren M, Pals ST. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. BLOOD 2002;99(4):1405-1410.     [ PubMed ]

 

  • Hagenbeek A, Czuczman MS, Ghielmini M, Herold M, Kimby E, Solal-Céligny P, Unterhalt M. Rituximab therapy for indolent non-Hodgkin's lymphoma. ANTI-CANCER DRUG 2002;13(Suppl. 2):S11-S17.     [ PubMed ]

 

  • Hazenberg MD. T cell turnover and thymic function in HIV-1 infection. S.l.: s.n.; 2002. (207pp.) (PhD thesis. Supervisor(s):  Miedema F; co-supervisor(s):  Hamann D, de Boer RJ) [ UvA Dissertations Online ]

 

  • Hazenberg MD. T-cell turnover during HIV infection. AIDS READ 2002;12:S10-S13.  

 

  • Hazenberg MD, Otto SA, de Pauw ES, Roelofs H, Fibbe WE, Hamann D , Miedema F. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. BLOOD 2002;99(9):3449-3453.     [ PubMed ]

 

  • Hazenberg MD, Otto SA, Wit FWNM, Lange JMA, Hamann D, Miedema F. Discordant responses during antiretroviral therapy role of immune activation and T cell redistribution rather than true CD4 T cell loss. AIDS 2002;16(9):1287-1289.     [ PubMed ]

 

  • Jonkhoff AR, de Kreuk AM, Franschman G, van der Lelie J, Schuurhuis GJ, Dräger AM, Zweegman S, Huijgens PC, Ossenkoppele GJ. Granulocyte colony-stimulating factor mobilized whole blood containing over 0 center dot 3 x 10(6)/kg CD34(+) cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma. BRIT J HAEMATOL 2002;118(1):90-100.  

 

  • Kater AP, Peppelenbosch MP, Brandjes DPM, Lumbantobing M. Dichotomal effect of the coumadin derivative warfarin on inflammatory signal transduction. CLIN DIAGN LAB IMMUN 2002;9(6):1396-1397.     [ PubMed ]

 

  • Kater AP , van der Lelie J, Levi M. Trombotische microangiopathie: trombocytopenie en hemolytische anemie. NED TIJDSCHR GENEESKD 2002;146(49):2343-2347.     [ PubMed ]

 

  • Kater AP , van Oers MHJ. Immunogentherapie. Bestrijding leukemie door activatie afweersysteem met behulp van CD70. ANALYSE (AMSTERDAM) 2002;-(oktober):240-242.  

 

  • Kostense S, Otto SA, Knol GJ, Manting EH, Nanlohy NM, Jansen C, Lange JMA, van Oers MHJ, Miedema F, van Baarle D. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells. EUR J IMMUNOL 2002;32(4):1080-1089.     [ PubMed ]

 

  • Mackus WJM, Lens SMA, Medema RH, Kwakkenbos MJ, Evers LM, Oers MHJv, van Lier RAW, Eldering E. Prevention of B cell antigen receptor-induced apoptosis by ligation of CD40 occurs downstream of cell cycle regulation. INT IMMUNOL 2002;14(9):973-982.     [ PubMed ]

 

  • Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsi V, Meuer S, Morissey J, Schwartz-Albiez R, Shaw S, Simmons D, Uguccioni M, van der Schoot CE, Vivier E, Zola H. CD antigens 2002. BLOOD 2002;99(10):3879-3880.  

 

  • Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsi V, Meuer S, Morrissey JH, Schwartz-Albiez R, Shaw S, Simmons D, Uguccioni M, van der Schoot CE, Vivier E, Zola H. CD antigens 2001. MODERN PATHOL 2002;15(1):71-76.

  

  • Rijnders RJP, Christiaens GCML, Bossers B, van der Schoot CE. Het adrenogenitaal syndroom: klinische aspecten en neonatale screening. NED TIJDSCHR GENEESKD 2002;146(36):1713-4; author reply 1714.     [ PubMed ]

 

  • Tax MGHM, van der Schoot CE, van Doorn R, Douglas-Berger L, van Rhenen DJ, Maaskant-vanWijk PA. RHC and RHc genotyping in different ethnic groups. TRANSFUSION 2002;42(5):634-644.     [ PubMed ]

 

  • van Agthoven M, Groot MT, Verdonck LF, Löwenberg B, Schattenberg AVMB, Oudshoorn M, Hagenbeek A, Cornelissen JJ, Uyl-de Groot CA, Willemze R. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia. BONE MARROW TRANSPL 2002;30(4):243-251.     [ PubMed ]

 

  • van Baarle D, Kostense S, Hovenkamp E, Ogg G, Nanlohy N, Callan MFC, Dukers NHTM, McMichael AJ, van Oers MHJ, Miedema F. Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection. AIDS 2002;16(15):2001-2011.     [ PubMed ]

 

  • van Baarle D, Kostense S, van Oers MHJ, Hamann D, Miedema F. Failing immune control as a result of impaired CD8(+) T-cell maturation: CD27 might provide a clue. TRENDS IMMUNOL 2002;23(12):586-591.     [ PubMed ]

 

  • van Baarle D, Wolthers KC, Hovenkamp E, Niesters HGM, Osterhaus ADME, Miedema F, van Oers MHJ. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J INFECT DIS 2002;186(3):405-409.     [ PubMed ]

 

  • van Buul JD, Voermans C, van den Berg V, Anthony EC, Mul FPJ, van Wetering S, van der Schoot CE, Hordijk PL. Migration of human hematopoietic progenitor cells across bone marrow endothelium is regulated by vascular endothelial cadherin. J IMMUNOL 2002;168(2):588-596.     [ PubMed ]

 

  • van der Kolk LE, Baars JW, Prins MH, van Oers MHJ. Rituximab treatment results in impaired secondary humoral immune responsiveness. BLOOD 2002;100(6):2257-2259.     [ PubMed ]

 

  • van der Kolk LE, de Haas M, Grillo-López AJ, Baars JW, van Oers MHJ. Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophils. LEUKEMIA 2002;16(4):693-699.     [ PubMed ]

 

  • van der Kolk LE, Evers LM, Omene C, Lens SMA, Lederman S, van Lier RAW, van Oers MHJ, Eldering E. CD20-induced B cell death can bypass mitochondria and caspase activation. LEUKEMIA 2002;16(9):1735-1744.     [ PubMed ]

 

  • van der Velden VHJ, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJM. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. LEUKEMIA 2002;16(5):928-936.     [ PubMed ]

 

  • van der Vliet HJJ, van Oers MHJ, Schot LJ, Majoie CBL, van der Meer JTM. A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient. ANN HEMATOL 2002;81(3):164-166.     [ PubMed ]

 

  • van der Vliet HJJ, von Blomberg BME, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, Prins M, Claessen FA, van den Eertwegh AJM, Giaccone G, Miedema F, Scheper RJ, Pinedo HM. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J IMMUNOL 2002;168(3):1490-1495.     [ PubMed ]

 

  • van Lier RAW, van Oers MJH. Curtailing BCR signaling. BLOOD 2002;100(9):3061.  

 

  • van Oers MHJ, Hagenbeek A, van Glabbeke M, Teodorovic I. Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study. ANN HEMATOL 2002;81(10):553-557.     [ PubMed ]

 

  • Vermeulen M, van Oers MH. Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J NEUROL NEUROSUR PS 2002;72(1):127-128.     [ PubMed ]

 

  • Voermans C, van Heese WPM, de Jong I, Gerritsen WR, van der Schoot CE. Migratory behavior of leukemic cells from acute myeloid leukemia patients. LEUKEMIA 2002;16(4):650-657.     [ PubMed ]

 

  • Weijtens M, van Spronsen A, Hagenbeek A, Braakman E, Martens A. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats. HUM GENE THER 2002;13(2):187-198.     [ PubMed ]